MétaCan
Menu
Back to cohort
Record W4213412991 · doi:10.1016/j.jhepr.2022.100462

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

2022· article· en· W4213412991 on OpenAlexafffund
A Howe, Chaturaka Rodrigo, Evan B. Cunningham, Mark W. Douglas, Julia Dietz, Jason Grebely, Stephanie Popping, Javier Alejandro Sfalcin, Miłosz Parczewski, Christoph Sarrazin, Adolfo de Salazar, Ana Fuentes, Murat Sayan, Josep Quer, Midori Kjellin, Hege Kileng, Orna Mor, Johan Lennerstrand, Slim Fourati, Velia Chiara Di Maio, Vladimir Chulanov, Jean–Michel Pawlotsky, P. Richard Harrigan, Francesca Ceccherini‐Silberstein, Féderico García, Marianne Martinello, Gail Matthews, Fay Fabián Fernando, Juan Ignacio Esteban, Beat Müllhaupt, Julian Schulze zur Wiesch, Peter Buggisch, Christoph Neumann‐Haefelin, Thomas Berg, Christoph P. Berg, Jörn M. Schattenberg, Christophe Moreno, Rudolf Stauber, Andrew R. Lloyd, Gregory J. Dore, Tanya Applegate, Juan Ignacio, Damir García‐Cehic, Josep Gregori, Francisco Rodríguez‐Frias, Yael Gozlan, M. Angélico, Massimo Andreoni, Sergio Babudieri, Ada Bertoli, Valeria Cento, Nicola Coppola, Antonio Craxı̀, Stefania Paolucci, Giustino Parruti, C. Pasquazzi, Carlo Federico Perno, Elisabetta Teti, C. Vironet, Anders Lannergård, Ann‐Sofi Duberg, Soo Aleman, Tore Jarl Gutteberg, Alexandre Soulier, Aurélie Gourgeon, Stéphane Chevaliez, Stanislas Pol, Fabrice Carrat, Dominique Salmon‐Céron, Rolf Kaiser, Elena Knopes, Perpétua Gómes, Rob de Kneght, Bart Rijnders, Mario Poljak, Maja M. Lunar, Rafael Usubillaga, Enoch Tay, Caroline Wilson, Dao Sen Wang, Jacob George, Jen Kok, Ana Belén Pérez, Natalia Chueca, Miguel García Deltoro, Ana Martínez-Sapiña, María Magdalena Lara-Pérez, Silvia García‐Bujalance, Teresa Aldámiz‐Echevarría, Francisco Jesús Vera-Méndez, Juan A. Pineda, Marta Casado, J.M. Pascasio, Javier Salmerón, Juan Carlos Alados, Antonio Poyato, Francisco Téllez, Antonio Rivero‐Juárez, Dolores Merino, María Jesús Vivancos, José Miguel Rosales Zábal, María Dolores Ocete, Miguel Ángel Simón, Pilar Rincón, Sergi Reus, Isabel García-Arata, Miguel Jiménez, Fernando Jiménez, José Hernández‐Quero, Carlos Galera, Mohamed Omar Balghata, J Primo, Mar Masiá, Núria Espinosa, Marcial Delgado, Miguel Ángel Von-Wichmann, Antonio Collado, Jesús Santos, Carlos Mínguez, Felícitas Díaz-Flores, Elisa Fernández, Enrique Bernal, José Joaquín Antón, Mónica Vélez, Antonio Aguilera, Daniel Navarro, Juan Ignacio Arenas, Clotilde Fernández, María Dolores Espinosa, María Rios, Roberto Alonso, Carmen Hidalgo, Rosario Hernández, María Jesús Téllez, Francisco J. Rodríguez‐Valadez, Pedro Antequera, Cristina Delgado, Patrícia Martin, Javier Crespo, B. Becerril, Óscar Pérez, Antonio García‐Herola, J.L. Montero, Carolina Freyre, Concepción Grau, Joaquín Cabezas, Miguel A. Jiménez, Manuel Alberto Macías Rodríguez, Cristina Quílez, Maria Rodriguez Pardo, Leopoldo Muñoz‐Medina, Blanca Figueruela

Bibliographic record

VenueJHEP Reports · 2022
Typearticle
Languageen
FieldMedicine
TopicHepatitis C virus research
Canadian institutionsUniversity of British ColumbiaBC Centre for Disease Control
FundersNational Health and Medical Research CouncilMinistero dell’Istruzione, dell’Università e della RicercaMinistero della SaluteGilead SciencesUniversity of SydneyDepartment of Health and Ageing, Australian GovernmentGenome British ColumbiaMerck
KeywordsNS5ANS5BMedicineHepatitis C virusSofosbuvirDrug resistanceVirologyNS3Internal medicineRibavirinVirusHepacivirusBiologyMicrobiology

Abstract

fetched live from OpenAlex

Background & Aims: Direct-acting antiviral (DAA) regimens provide a cure in >95% of patients with chronic HCV infection. However, in some patients in whom therapy fails, resistance-associated substitutions (RASs) can develop, limiting retreatment options and risking onward resistant virus transmission. In this study, we evaluated RAS prevalence and distribution, including novel NS5A RASs and clinical factors associated with RAS selection, among patients who experienced DAA treatment failure. Methods: SHARED is an international consortium of clinicians and scientists studying HCV drug resistance. HCV sequence linked metadata from 3,355 patients were collected from 22 countries. NS3, NS5A, and NS5B RASs in virologic failures, including novel NS5A substitutions, were examined. Associations of clinical and demographic characteristics with RAS selection were investigated. Results: The frequency of RASs increased from its natural prevalence following DAA exposure: 37% to 60% in NS3, 29% to 80% in NS5A, 15% to 22% in NS5B for sofosbuvir, and 24% to 37% in NS5B for dasabuvir. Among 730 virologic failures, most were treated with first-generation DAAs, 94% had drug resistance in ≥1 DAA class: 31% single-class resistance, 42% dual-class resistance (predominantly against protease and NS5A inhibitors), and 21% triple-class resistance. Distinct patterns containing ≥2 highly resistant RASs were common. New potential NS5A RASs and adaptive changes were identified in genotypes 1a, 3, and 4. Following DAA failure, RAS selection was more frequent in older people with cirrhosis and those infected with genotypes 1b and 4. Conclusions: Drug resistance in HCV is frequent after DAA treatment failure. Previously unrecognized substitutions continue to emerge and remain uncharacterized. Lay summary: Although direct-acting antiviral medications effectively cure hepatitis C in most patients, sometimes treatment selects for resistant viruses, causing antiviral drugs to be either ineffective or only partially effective. Multidrug resistance is common in patients for whom DAA treatment fails. Older patients and patients with advanced liver diseases are more likely to select drug-resistant viruses. Collective efforts from international communities and governments are needed to develop an optimal approach to managing drug resistance and preventing the transmission of resistant viruses.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.020
Threshold uncertainty score0.997

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.333
Teacher spread0.309 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations42
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueJHEP ReportsSame topicHepatitis C virus researchFrench-language works237,207